ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2011

Aug 17, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2011-08-16

Reporting Person: JACOBS CINDY (EVP, CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-16	Common Stock	M	11210	$4.1051	Acquired	21210	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-16	Stock Options	$4.1051	M	11210	Disposed	2012-09-12	Common (11210)	Direct

Footnotes

F1: Since the date of the reporting person's last ownership report, she transferred options representing 6,011 shares of the issuer's common stock to her ex-spouse pursuant to a domestic relations order.